chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer Dose #1 - Jan 22, 2021 - Symptom:  arm pain, fatigue Pfizer Dose #2 - Feb 16, 2021 (11:57am) - Death approximately 12 hours later before 1am 02/17/2021.
Went into labor prior to the due date with complications to my baby. My baby was born with two collapsed lungs due to sepsis and meconium aspiration. He was diagnosed with pulmonary hypertension and respiratory failure.  My due date was 9/24/2021 but I was scheduled for a repeat section 9/22/2021. I was extremely tired 9/19/2021 but figured it was just because I was pregnant. However, the morning of 9/20/2021 I noticed decreased movements from my baby and I didn't feel well, very tired with chills and uncontrollable shaking. When I went to the hospital I was quickly taken back for an emergency c-section when they noticed I was having contractions and my baby's heart rate was continuing to drop. Within 16 hours of
This spontaneous report was received from a nurse, referring to multiple unspecified patients. The nurse reported that on multiple unspecified dates, multiple different unspecified patients were administered improperly stored VARIVAX (Merck) lot # L02000, expiration date 02-JUN-2017, lot # L013824, expiry date 21-APR-2017. The nurse enquired about the stability of ZOSTAVAX, but none was administered. On 26-OCT-2015, the nurse reported that on multiple unspecified dates, multiple different unspecified patients were administered improperly stored VARIVAX (Merck) lot # L013824, expiry date 21-APR-2017 after the previously reported temperature excursions. No adverse effects were reported. The ZOSTAVAX, lot # L013546, expiration date 17-JUL-2016 and other lot numbers of VARIVAX (Merck) lot # L02000, expiration date 02-JUN-2017 and lot # L026410, expiration date 15-FEB-2017 appeared on the product list, since the stability was enquired about these vaccines. No doses of ZOSTAVAX, was administered. This case is one of the two reports with the same reporter link. Additional information has been requested.
This spontaneous report as received from a health care worker refers to a patient of unknown age and gender. On 05-AUG-2013 the patient was vaccinated with a dose of VARIVAX (Merck) (lot # J006109, expiry date 21-MAY-2015) (dose, route, injection site not provided). The VARIVAX (Merck) underwent an unsupported temperature excursion and was administered to the patient on 05-AUG-2013. No adverse effect reported. This is one of several reports reporting from same source. Additional information has been requested.
sore arm,aches; tiredness; pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm,aches), FATIGUE (tiredness) and PAIN (pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) and Thyroid medication for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced FATIGUE (tiredness) and PAIN (pain). On an unknown date, the patient experienced MYALGIA (sore arm,aches). On 27-Apr-2021, FATIGUE (tiredness) and PAIN (pain) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Arm discomfort at site of injection initially, then rash(mobiliform in nature) 5cmx5cm in size developed on day 10 and is just gone on March 4th. No adverse outcome at present.
The vaccine was placed on right thigh, the reaction was red, raised bump around injection site.  The area was hot to the touch and painful to touch as well. The patient did not want anyone touching his leg.
A nurse reported that a 3 month old male received Prevnar and IPV vaccines on 5/3/00 and since then, the infant has been sleeping "a lot more than normal, but is arousable." Follow up info received 6/13/00 indicated that the infant recovered.
I mixed COVID vaccine with insufficient amount of diluent.  I used 1cc insulin syringe, that was in with COVID supplies to draw up diluent and mix into vaccine to prepare vial for administration.  I used only 0.8 cc (80 unit mark) of diluent incorrectly, instead of 1.8 cc.  Booster doses of vaccine were then given to patients using solution of incorrect concentration.   When RN went to give what would have been 4th dose from vial, vial was found to be empty.   Patient was notified of error. Discussed possibility of heightened immune response.
This spontaneous report as received from a Licensed Practical Nurse refers to a 7 and a half months year male patient. On 16-SEP-2014 the patient was vaccinated with a first dose of ROTATEQ oral, 1 dose (lot # not reported). On 16-SEP-2014 the patient received his first dose of oral ROTATEQ at age of 7 and a half months. no adverse effect was reported. Additional information has been requested.
Bright pink rash 4? long 2? wide, slightly itchy, warm to touch, only  slightly tender
The COVID-19 vaccine administered through vaccine administrator, HCF, between June 25 and July 30 came from the lot number 039K20A.  It was discovered that this particular lot was beyond its frozen expiration date by five (5) up to forty (40) days. A case was opened with Moderna (Case #: MOD21-126790).  Please refer to this case number if you would like to contact Moderna directly.  Moderna confirmed that the vaccine doses administered maintained the activity necessary to protect against the COVID-19 virus.  Moderna also confirmed there is no danger to anyone's health from receiving a vaccine past its frozen expiration date.  No adverse reactions were identified.
The patient got COVID; The patient got COVID; Dose Number 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 18Nov2021 (Batch/Lot number: unknown) at the age of 31 years as dose 3 (booster), single, administration date 16May2021 (Batch/Lot number: unknown) as dose 2, single and administration date 25Apr2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant) with onset 18Nov2021, outcome "unknown", described as "Dose Number 3"; DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 03Jan2022, outcome "recovered" (Jan2022) and all described as "The patient got COVID". The event "the patient got COVID" was evaluated at the physician office visit. Therapeutic measures were taken as a result of drug ineffective, suspected COVID-19. These events did not result in hospitalization prolonged. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed as COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Sunday morning following my booster shot, I awoke to severe neck pain and immobility. The pain was from the base of my skull down to my shoulder blade and only on the left side of my spine (the side I received my booster). I could not lift my head up off of my pillow and had to roll sideways out of bed to get up. I could not turn my head left or right, and I couldn?t look up or down.
PATIENT STATES HE HAS RANDOM TWITCH IN LEFT FOREARM WHICH STARTED A FEW DAYS AFTER VACCINE. NO PAIN OR DISCOMFORT HOWEVER CERTAIN WAYS HE MOVES HIS ARM IT WILL BE SORE BUT HE IS NOT SURE IF THAT IS DUE TO PAST ROTATER CUFF  INJURY. HE DOES LIFT WEIGHTS. STATES INJECTION SITE WAS NOT RED OR SWOLLEN OR ANY MORE SORE THEN NORMAL AFTER A VACCINE
tingling sensation on tongue; jittery; Skin was prickly on back and arms; Minor red rash and red dots spread out; itchy feeling inside him; rash on both lower legs; arm hurt for 12 hours; A Spontaneous report was received from a consumer concerning a 49 year old, male patient who was participating in the mRNA-1273 Emergency Use Program and experienced several adverse events.  The patient reported, he has allergies to several different things. No relevant concomitant medications were reported.   While participating in this program, the patient experienced the adverse events. The patient received their first of two planned doses of mRNA-1273 on 05 JAN 2021, intramuscularly in the left arm for prophylaxis of COVID-19 infection.    Initially his arm hurt for 12 hours.  On 17Jan2021, 12 days later, he noticed rash on lower legs (patient clarified both legs).  Then 15 days later, he developed itchy feeling inside him. His skin was prickly on back and arms, tingling sensation on tongue. He describes minor red rash, red dots spread out.  He felt jittery, like he had coffee.  Treatment for the event included steroids and cetirizine.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the events were unknown.
I had the second dose on 03/27/2021. I got the main symptoms of headache, body aches, pains the following day. I went to urgent care 3 days later, Tuesday 30th. Went in for pain I thought I had a rib out, they had a chiropractor checked me out, he did not do anything, I went to urgent care twice. Both times my lungs were clear. No pneumonia. They did an x-ray which was clear. I had nebulizer treatment, and then it came back to the same. I went to the doctor the following week on 04/13/2021 and he checked me over and could not find anything. He heard some crackling in the lower part of my lungs, which he found interesting but he could not find out why I was having that pain. I left there. Before getting home he called me and said that it could be a sign of a blood clot. He had me get a CT scan, I got it in 06/14/2021. They found that I had 1 blood clot on each lung. The biggest one on the right one. They gave me blood thinners. I had fluids on my lungs. They were not able to take it all out so I might have to have surgery. The blood clots have resolved themselves with the medication.
L arm injection site painful, swollen, 8 cm lump and red/warm at site approx 1 hour after injection. Swelling spread down deltoid to elbow and lasted about 3 days. Headache noted.
SLEEP APNEA; This spontaneous report received from a patient concerned an adult male. The patient's height, and weight were not reported. The patient's concurrent conditions included: rheumatoid arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. Non-company suspect drugs included: adalimumab (solution for injection, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for rheumatoid arthritis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced sleep apnea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The patient had not recovered from sleep apnea. This report was non-serious.
Headache within 2 hours of receiving vaccine.  Resolved 3 hours after taking Advil.  Severe chills, arthralgia, weakness and fatigue within 6 hours of receiving the vaccine. Required Advil every 4 hours for about 24 hours.  Muscular soreness, minimal swelling at the incision site for 3 days. No redness.
6/10/03 Left arm red, tender 15 x 8cm with altered sensation of the hand. Dx: Allergic reaction. Rx: Prednisone 20mg
Information has been received from a consumer concerning her 18 year old sister who on 7/26/04 was vaccinated with a dose of varicella virus vaccine live. The reporter indicated that shortly after vaccination, on approximately 7/26/04, the patient developed 14 pox-like lesions, body aches, and fatigue. The patient's physician instructed her to apply over the counter calamine lotion to the lesions. At the time of the report, the adverse events were improving on therapy and the patient was recovering. A product quality complaint was not involved. Follow up information was received from a physician who indicated that the patient received varicella virus vaccine live on 7/15/04. The reporter noted that the patient's chart showed no record of an adverse event. No further information is expected.
One week post vax, pt reported injection site pain which radiated throughout her arm; she was unable to move her arm as a result of the pain.  Pt was treated with nonsteroidal anti-iflammatories. As of 01/28/1999 she continued to experience pain.
DILATED EYES, BRIGHTNESS SINCE THE DAY OF VACCINE AND IT HAS NOT GOTTEN BETTER.
Moderate pain at site of administration + for about 18 hours after, which was expected; Around 01/18/2021 pain returned, increasing in severity, took ibuprofen 800 mg in morning and evening; 01/19/2021 took ibuprofen 800 mg in morning and evening; in evening had sudden onset rash around and below site of administration, very warm, very red, sharply-bordered, mildly itchy, perhaps 3 square inches in size, applied 1% hydrocortisone; 01/20/2021 rash had increased in size overnight by perhaps a half inch, took ibuprofen 800 mg morning and evening; in evening went to Urgent Care who advised it did not seem infections, allergic, or injured and was likely a benign side effect of vaccine, so prescribed meloxicam and triamcinolone 0.1%; 01/21/2021 - 01/22/2021 symptoms well controlled with meloxicam 7.5 mg twice daily and triamcinolone 0.1% twice daily and subsiding 01/23/2021 rash is gone, pain minimal
Constricted throat. I was given Zyrtec. Observed for an hour. Got discharged. Throat constriction didn't go away until 2 hours afterwards. Puffy, itchy eyes (both eyes) with rash came and lasted about two weeks. Monday or Tuesday, I noticed a rash all over my body - red and blotchy. That went away in a day. I got chills, fever, weakness, nausea, vomiting, diarrhea and that lasted 48 hours (16th in pm-17th and got better evening of 18th). When I had the rash was all over the body, I took a Zyrtec. The weekend I was really sick I didn't take any medication.  Phone visit with Doctor  - January 15th - allergist - I followed up with him about the throat constriction. He just was monitoring symptoms. After the weekend that I was really sick,  I told him and he ordered bloodwork.
Antibody testing results which indicated a severe allergic reaction/ serious adverse event.; Injection arm went numb from her elbow to her fingers.; Felt like sugars were low for about 5 hours; Dizziness; Muscle pain; Joint pain; Couldn't do anything and she was very fatigue and exhausted; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Antibody testing results which indicated a severe allergic reaction/ serious adverse event.), INJECTION SITE HYPOAESTHESIA (Injection arm went numb from her elbow to her fingers.), BLOOD GLUCOSE DECREASED (Felt like sugars were low for about 5 hours), DIZZINESS (Dizziness) and MYALGIA (Muscle pain) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced HYPERSENSITIVITY (Antibody testing results which indicated a severe allergic reaction/ serious adverse event.), INJECTION SITE HYPOAESTHESIA (Injection arm went numb from her elbow to her fingers.), BLOOD GLUCOSE DECREASED (Felt like sugars were low for about 5 hours), DIZZINESS (Dizziness), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), FATIGUE (Couldn't do anything and she was very fatigue and exhausted) and HEADACHE (Headache). At the time of the report, HYPERSENSITIVITY (Antibody testing results which indicated a severe allergic reaction/ serious adverse event.), INJECTION SITE HYPOAESTHESIA (Injection arm went numb from her elbow to her fingers.), BLOOD GLUCOSE DECREASED (Felt like sugars were low for about 5 hours), DIZZINESS (Dizziness), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and FATIGUE (Couldn't do anything and she was very fatigue and exhausted) outcome was unknown and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported
Could not stand up after 3rd shot; Humongous Knot on the left arm injection site after 3rd shot; Chills after 3rd shot; fever 99 Fahrenheit/Increased Fever 102.8 F after 3rd shot; Felt dizzy after 3rd shot; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy after 3rd shot), DYSSTASIA (Could not stand up after 3rd shot), VACCINATION SITE MASS (Humongous Knot on the left arm injection site after 3rd shot), CHILLS (Chills after 3rd shot) and PYREXIA (fever 99 Fahrenheit/Increased Fever 102.8 F after 3rd shot) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A, 043L20A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Sep-2021, the patient experienced DIZZINESS (Felt dizzy after 3rd shot), CHILLS (Chills after 3rd shot) and PYREXIA (fever 99 Fahrenheit/Increased Fever 102.8 F after 3rd shot). On 18-Sep-2021, the patient experienced DYSSTASIA (Could not stand up after 3rd shot) and VACCINATION SITE MASS (Humongous Knot on the left arm injection site after 3rd shot). At the time of the report, DIZZINESS (Felt dizzy after 3rd shot), DYSSTASIA (Could not stand up after 3rd shot), VACCINATION SITE MASS (Humongous Knot on the left arm injection site after 3rd shot), CHILLS (Chills after 3rd shot) and PYREXIA (fever 99 Fahrenheit/Increased Fever 102.8 F after 3rd shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Sep-2021, Body temperature: 99 f (High) Fever of 99 F. On 18-Sep-2021, Body temperature: 102.8 f (High) fever of 102.8 F.         Concomitant medications were not provided. Treatment medications were not provided. The patient  could not shower.
vaccinated with Pfizer 1st dose 4 days ago. Having some headache, chills. No fever but feels warm.
Strong headache, mild nausea, tired, arms were  like Jell-O, those started 20 minutes after the vaccine and lasted for 2 1/2 days. The next day was the soreness around the injection site.
Information has been received from a doctor of dental surgery concerning a white 32 year old dental assistant, gravida III, female with a codeine allergy who on 6/18/02, was "inadvertently" vaccinated with 3ml of hep B vaccine recombinant(638671/0656L). There was no concomitant medication. Follow-up info was received from the doctor of dental surgery. There was no illness at the time of the vaccination. On 6/18/02, the pt developed a slight diarrhea for one day, experienced muscle soreness at the injection site for three days and slight muscle soreness in the trapezius (bilaterally) for three days. The pt recovered three days after administration of the vaccination. The doctor of dental surgery reported that the pt did not "really require medical intervention per the symptoms, but the doctor of dental medicine believed that it was necessary to follow up with a physician visit. On 7/3/02, the pt's serum hep B surface antibody screen was >150.0mIU/mL. It was reported that there was "no need for further HBV shots. Started series a few years back and looks like she is immune." Additional follow up info was received from the doctor of dental surgery who reported that his office was "scared" over this event of overdose. He reported that he "could not find info int he product circular." Therefore, the office referred the pt to her medical doctor for monitoring. The doctor of dental surgery reported that the pt did not require any intervention and recovered from the event. The doctor of dental surgery suggested that hep B vaccine recombinant not be packaged in multidose vials. The administering doctor of dental medicine had given the hep B vaccine recombinant in the past from one-dose vials. When administering this dose of hep B vaccine recombinant, she did not realize that it was a multidose vial and drew up the entire contents and administered the vaccination. The reporter indicated that the pt required medical intervention to prevent a serious medical event (OMIC). No additional info is available.
Received 2nd Pfizer vaccine et developed horseshoe shaped rash ~ March 30
Worsened Atrial Fibulation (AFIB). The AFIB became near constant and led to an ablation on April 29th to remedy the situation
Today is Wednesday, on Monday at 1600 pt received TRUMENBA to the left deltoid. Around 1800 Left arm started to get sore and numb. Then by 2300 had body aches and then by 6 am. Had nausea, vomiting and diarrhea that lasted a few hours. Her body then began to hurt more--describes widespread muscle aches. No rashes. She tried to go to work but had to go home. She did report a fever of 102.6 last night. This morning she had a headache to the frontal part of her head and her eyes. No mention of photophobia.